Vital Pulp Therapy
14
2
3
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
14%
2 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (14)
Bioactive Materials in Vital Pulp Therapy of Permanent Teeth
Diagnostic Validity of a Quantitative Pulp Pain Scoring System and Its Association With Postoperative Clinical Outcomes
Evaluation of the Success of TheraCal PT in Pulpotomy Treatment of Primary Teeth Using Low-Level Laser Therapy
Vital Pulp Therapy With Different Materials for Young Permanent Teeth
Evaluation of Pulpal Biomarkers in Vital Pulp Therapy
Comparative Evaluation of the Clinical Outcome of Direct Pulp Capping Treatment in Permanent Molars
Comparative Evaluation of Melatonin Versus MTA on Vital Pulp Therapy in Young Permanent First Molars: An in Vivo Study
Vital Pulp Therapy of Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material
Knowledge of Vital Pulp Therapy in Permanent Teeth Among a Group of Dental Students in Egypt
Comparative Evaluation of Three Pulpotomy Agents for Permanent Mature Molars With Irreversible Pulpitis
Knowledge, Attitude and Practice in Utilization of Vital Pulp Therapy in Permanent Teeth by Pediatric Dentists in Egypt
Pulp Capping in Primary Molars Using TheraCal (LC)
Diagnostic Biomarkers to Correlate Molecular Changes and Inflammatory Cascade in the Dental Pulp.
Effect of Topical Dexamethasone on Histologic Response of Human Dental Pulp